382 related articles for article (PubMed ID: 28411117)
1. In vitro α-synuclein neurotoxicity and spreading among neurons and astrocytes using Lewy body extracts from Parkinson disease brains.
Cavaliere F; Cerf L; Dehay B; Ramos-Gonzalez P; De Giorgi F; Bourdenx M; Bessede A; Obeso JA; Matute C; Ichas F; Bezard E
Neurobiol Dis; 2017 Jul; 103():101-112. PubMed ID: 28411117
[TBL] [Abstract][Full Text] [Related]
2. α-Synuclein transfer between neurons and astrocytes indicates that astrocytes play a role in degradation rather than in spreading.
Loria F; Vargas JY; Bousset L; Syan S; Salles A; Melki R; Zurzolo C
Acta Neuropathol; 2017 Nov; 134(5):789-808. PubMed ID: 28725967
[TBL] [Abstract][Full Text] [Related]
3. Sequestration of synaptic proteins by alpha-synuclein aggregates leading to neurotoxicity is inhibited by small peptide.
Choi MG; Kim MJ; Kim DG; Yu R; Jang YN; Oh WJ
PLoS One; 2018; 13(4):e0195339. PubMed ID: 29608598
[TBL] [Abstract][Full Text] [Related]
4. 14-3-3 Proteins Reduce Cell-to-Cell Transfer and Propagation of Pathogenic α-Synuclein.
Wang B; Underwood R; Kamath A; Britain C; McFerrin MB; McLean PJ; Volpicelli-Daley LA; Whitaker RH; Placzek WJ; Becker K; Ma J; Yacoubian TA
J Neurosci; 2018 Sep; 38(38):8211-8232. PubMed ID: 30093536
[TBL] [Abstract][Full Text] [Related]
5. Proteolytic cleavage of extracellular α-synuclein by plasmin: implications for Parkinson disease.
Kim KS; Choi YR; Park JY; Lee JH; Kim DK; Lee SJ; Paik SR; Jou I; Park SM
J Biol Chem; 2012 Jul; 287(30):24862-72. PubMed ID: 22619171
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylation at S87 is enhanced in synucleinopathies, inhibits alpha-synuclein oligomerization, and influences synuclein-membrane interactions.
Paleologou KE; Oueslati A; Shakked G; Rospigliosi CC; Kim HY; Lamberto GR; Fernandez CO; Schmid A; Chegini F; Gai WP; Chiappe D; Moniatte M; Schneider BL; Aebischer P; Eliezer D; Zweckstetter M; Masliah E; Lashuel HA
J Neurosci; 2010 Mar; 30(9):3184-98. PubMed ID: 20203178
[TBL] [Abstract][Full Text] [Related]
7. Impact of monomeric, oligomeric and fibrillar alpha-synuclein on astrocyte reactivity and toxicity to neurons.
Chavarría C; Rodríguez-Bottero S; Quijano C; Cassina P; Souza JM
Biochem J; 2018 Oct; 475(19):3153-3169. PubMed ID: 30185433
[TBL] [Abstract][Full Text] [Related]
8. Endocytic vesicle rupture is a conserved mechanism of cellular invasion by amyloid proteins.
Flavin WP; Bousset L; Green ZC; Chu Y; Skarpathiotis S; Chaney MJ; Kordower JH; Melki R; Campbell EM
Acta Neuropathol; 2017 Oct; 134(4):629-653. PubMed ID: 28527044
[TBL] [Abstract][Full Text] [Related]
9. Development of alpha-synuclein immunoreactive astrocytes in the forebrain parallels stages of intraneuronal pathology in sporadic Parkinson's disease.
Braak H; Sastre M; Del Tredici K
Acta Neuropathol; 2007 Sep; 114(3):231-41. PubMed ID: 17576580
[TBL] [Abstract][Full Text] [Related]
10. Lewy body-like α-synuclein aggregates resist degradation and impair macroautophagy.
Tanik SA; Schultheiss CE; Volpicelli-Daley LA; Brunden KR; Lee VM
J Biol Chem; 2013 May; 288(21):15194-210. PubMed ID: 23532841
[TBL] [Abstract][Full Text] [Related]
11. Mapping of rat brain using the Synuclein-1 monoclonal antibody reveals somatodendritic expression of alpha-synuclein in populations of neurons homologous to those vulnerable to Lewy body formation in human synucleopathies.
Andringa G; Du F; Chase TN; Bennett MC
J Neuropathol Exp Neurol; 2003 Oct; 62(10):1060-75. PubMed ID: 14575241
[TBL] [Abstract][Full Text] [Related]
12. α-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells.
Hansen C; Angot E; Bergström AL; Steiner JA; Pieri L; Paul G; Outeiro TF; Melki R; Kallunki P; Fog K; Li JY; Brundin P
J Clin Invest; 2011 Feb; 121(2):715-25. PubMed ID: 21245577
[TBL] [Abstract][Full Text] [Related]
13. Selective neuronal vulnerability in Parkinson disease.
Surmeier DJ; Obeso JA; Halliday GM
Nat Rev Neurosci; 2017 Jan; 18(2):101-113. PubMed ID: 28104909
[TBL] [Abstract][Full Text] [Related]
14. Munc18-1 is a molecular chaperone for α-synuclein, controlling its self-replicating aggregation.
Chai YJ; Sierecki E; Tomatis VM; Gormal RS; Giles N; Morrow IC; Xia D; Götz J; Parton RG; Collins BM; Gambin Y; Meunier FA
J Cell Biol; 2016 Sep; 214(6):705-18. PubMed ID: 27597756
[TBL] [Abstract][Full Text] [Related]
15. Molecular events underlying the cell-to-cell transmission of α-synuclein.
Choi YR; Park SJ; Park SM
FEBS J; 2021 Dec; 288(23):6593-6602. PubMed ID: 33332736
[TBL] [Abstract][Full Text] [Related]
16. Could α-synuclein amyloid-like aggregates trigger a prionic neuronal invasion?
Busquets MA; Espargaró A; Estelrich J; Sabate R
Biomed Res Int; 2015; 2015():172018. PubMed ID: 25866763
[TBL] [Abstract][Full Text] [Related]
17. Extensive uptake of α-synuclein oligomers in astrocytes results in sustained intracellular deposits and mitochondrial damage.
Lindström V; Gustafsson G; Sanders LH; Howlett EH; Sigvardson J; Kasrayan A; Ingelsson M; Bergström J; Erlandsson A
Mol Cell Neurosci; 2017 Jul; 82():143-156. PubMed ID: 28450268
[TBL] [Abstract][Full Text] [Related]
18. The process of Lewy body formation, rather than simply α-synuclein fibrillization, is one of the major drivers of neurodegeneration.
Mahul-Mellier AL; Burtscher J; Maharjan N; Weerens L; Croisier M; Kuttler F; Leleu M; Knott GW; Lashuel HA
Proc Natl Acad Sci U S A; 2020 Mar; 117(9):4971-4982. PubMed ID: 32075919
[TBL] [Abstract][Full Text] [Related]
19. Pathological roles of α-synuclein in neurological disorders.
Vekrellis K; Xilouri M; Emmanouilidou E; Rideout HJ; Stefanis L
Lancet Neurol; 2011 Nov; 10(11):1015-25. PubMed ID: 22014436
[TBL] [Abstract][Full Text] [Related]
20. Loss of functional alpha-synuclein: a toxic event in Parkinson's disease?
Kanaan NM; Manfredsson FP
J Parkinsons Dis; 2012; 2(4):249-67. PubMed ID: 23938255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
